Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metabolic Effects of Adjunctive Lumateperone in Clozapine-Treated Schizophrenia
NCT06174116Phase 4Recruiting
- Sponsor
- University of Massachusetts
- Start
- Apr 2024
- Primary completion
- Dec 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of lumateperone in schizophrenia, schizoaffective disorder, sponsored by University of Massachusetts. Started Apr 2024; status: recruiting.
02
Drugs
lumateperone
03
Conditions
schizophreniaschizoaffective disorder
Beyond the preview
Go deeper on NCT06174116.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06174116.